Related Experiment Video

Updated: Apr 5, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.7K

[Inhalation of Myramistin in the children presenting with acute respiratory diseases]

M A Khan1, N A Lian1, E L Vakhova1

  • 1GAUZ "Moskovskiĭ nauchno-prakticheskiĭ tsentr meditsinskoĭ reabilitatsii, vosstanovitel'noĭ i sportivnoĭ meditsiny" Departamenta zdravookhraneniia Moskvy.

Voprosy Kurortologii, Fizioterapii, I Lechebnoi Fizicheskoi Kultury
|August 20, 2015
PubMed

Insights

Myramistin inhalation solution effectively treats acute respiratory diseases in children by reducing inflammation and improving recovery. Nebulized Myramistin solution demonstrated superior therapeutic benefits compared to Myramistin spray.

Area of Science:

  • Pediatric Respiratory Medicine
  • Pharmacology
  • Clinical Research

Background:

  • Acute respiratory diseases are common in children.
  • Effective treatment options are crucial for pediatric respiratory health.

Purpose of the Study:

  • To evaluate the efficacy of Myramistin solution for inhalation in treating children with acute respiratory diseases.
  • To compare the effectiveness of nebulized Myramistin solution versus Myramistin spray.

Main Methods:

  • A study involving 60 children aged 2-17 with acute respiratory diseases.
  • Forty children received Myramistin solution via nebulizer; 20 children (control group) received Myramistin spray.
  • Clinical observations and special investigations were conducted.

Main Results:

  • Myramistin inhalation solution showed beneficial effects on clinical symptoms and peripheral blood characteristics.
  • Treatment accelerated patient recovery, attributed to anti-inflammatory and trophic actions.
  • Nebulized Myramistin solution was significantly more effective than Myramistin spray.

Conclusions:

  • Myramistin inhalation solution is an effective treatment for pediatric acute respiratory diseases.
  • The study supports the development of optimal Myramistin inhalation technologies for respiratory tract infections.
  • Nebulized administration of Myramistin solution offers superior therapeutic outcomes.
Abstract

More Related Videos

Intubation-mediated Intratracheal IMIT Instillation: A Noninvasive, Lung-specific Delivery System08:00

Intubation-mediated Intratracheal IMIT Instillation: A Noninvasive, Lung-specific Delivery System

Published on: November 17, 2014

25.7K
Intratracheal Administration of Dry Powder Formulation in Mice07:55

Intratracheal Administration of Dry Powder Formulation in Mice

Published on: July 25, 2020

12.6K

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.0K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
37
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
647